Cite
Futatsugi K, Huard K, Kung DW, et al. Small structural changes of the imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitors produce an improved safety profile. Medchemcomm. 2016;8(4):771-779doi: 10.1039/c6md00564k.
Futatsugi, K., Huard, K., Kung, D. W., Pettersen, J. C., Flynn, D. A., Gosset, J. R., Aspnes, G. E., Barnes, R. J., Cabral, S., Dowling, M. S., Fernando, D. P., Goosen, T. C., Gorczyca, W. P., Hepworth, D., Herr, M., Lavergne, S., Li, Q., Niosi, M., Orr, S. T. M., Pardo, I. D., Perez, S. M., Purkal, J., Schmahai, T. J., Shirai, N., Shoieb, A. M., Zhou, J., & Goodwin, B. (2017). Small structural changes of the imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitors produce an improved safety profile. MedChemComm, 8(4), 771-779. https://doi.org/10.1039/c6md00564k
Futatsugi, K, et al. "Small structural changes of the imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitors produce an improved safety profile." MedChemComm vol. 8,4 (2017): 771-779. doi: https://doi.org/10.1039/c6md00564k
Futatsugi K, Huard K, Kung DW, Pettersen JC, Flynn DA, Gosset JR, Aspnes GE, Barnes RJ, Cabral S, Dowling MS, Fernando DP, Goosen TC, Gorczyca WP, Hepworth D, Herr M, Lavergne S, Li Q, Niosi M, Orr STM, Pardo ID, Perez SM, Purkal J, Schmahai TJ, Shirai N, Shoieb AM, Zhou J, Goodwin B. Small structural changes of the imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitors produce an improved safety profile. Medchemcomm. 2016 Nov 22;8(4):771-779. doi: 10.1039/c6md00564k. eCollection 2017 Apr 01. PMID: 30108796; PMCID: PMC6072535.
Copy
Download .nbib